ENZO BIOCHEM INC (ENZ) Stock News
NYSE:ENZ - New York Stock Exchange, Inc. - US2941001024 - Common Stock - Currency: USD
ENZ Latest News, Press Relases and Analysis
Enzo Biochem, Inc. Announces Review of Strategic Alternatives after Receiving Multiple Inquiries Regarding a Potential Transaction
Forms Special Committee of the Board to Lead Evaluation of Viable Options for Maximizing Shareholder Value Engages Independent Financial and Legal...
Enzo Biochem, Inc. Announces Review of Strategic Alternatives after Receiving Multiple Inquiries Regarding a Potential Transaction
Why Argenx Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket
ENZ Stock Earnings: Enzo Biochem Reported Results for Q3 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Enzo Biochem (NYSE:ENZ) just reported results for the third quarter of 2024.Enz...
ENZ Stock Earnings: Enzo Biochem Reported Results for Q3 2024
Enzo Biochem just reported results for the third quarter of 2024.
ENZ Stock Earnings: Enzo Biochem Reported Results for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Enzo Biochem (NYSE:ENZ) just reported results for the first quarter of 2024.Enz...
ENZ Stock Earnings: Enzo Biochem Reported Results for Q1 2024
Enzo Biochem just reported results for the first quarter of 2024.
Enzo Biochem Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock and Transfer Trading of Shares to OTCQX
FARMINGDALE, N.Y., March 28, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced its intention to...
Enzo Biochem Reports Second Quarter Fiscal Year 2025 Results
FARMINGDALE, N.Y., March 17, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the...
Enzo Biochem Receives Notice of Non-Compliance with New York Stock Exchange Listing Rules
FARMINGDALE, N.Y, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced that it was notified by the...
Enzo Biochem Receives Notice of Non-Compliance with New York Stock Exchange Listing Rules
Enzo Biochem Reports First Quarter Fiscal Year 2025 Results and Provides a Company Update
FARMINGDALE, N.Y., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the...
Enzo Biochem Reports Fourth Quarter and Fiscal Year 2024 Results and Announces Cash Dividend
FARMINGDALE, N.Y., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the...
Enzo Biochem Reports Third Quarter Fiscal 2024 Results and Provides Business Update
FARMINGDALE, N.Y., June 13, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the...
Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update
FARMINGDALE, N.Y., March 13, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the second quarter ended January 31, 2024.
Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments
FARMINGDALE, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading life science company, announced...
Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments
ENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATE
FARMINGDALE, NY, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the...
ENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATE
ENZO BIOCHEM REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 RESULTS AND PROVIDES BUSINESS UPDATE
Steven J. Pully Appointed to Enzo Biochem’s Board of Directors
FARMINGDALE, NY, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or “the Company”), a leading life sciences company, announced...
Steven J. Pully Appointed to Enzo Biochem’s Board of Directors
Enzo Biochem names interim CEO (NYSE:ENZ)
Enzo Biochem (ENZ) said Wednesday that its CEO Hamid Erfanian, has stepped down and that Chief Operating Officer Kara Cannon will become interim CEO. Read more here.
Enzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEO
FARMINGDALE, NY, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) announced today that Hamid Erfanian, Chief Executive Officer (CEO),...